Sunday, April 20, 2014  
Sun Biomedical Limited (ASX:SBN)

Jack Kerins

Download MP3 Rate Interview Read Statistics
Interview MP3
 1 time(s)

Mr. Kerins has a 20 year history of successfully transitioning organizations from start up through to successful multi million dollar enterprises

Visit company website

Founded in 1993, Sun Biomedical Laboratories produces both urine and saliva based drugs of abuse testing devices at its facility in Blackwood, New Jersey, U.S.A. The company has established an industry benchmark with the most sensitive saliva drugs of abuse testing device available on the market today. The immediate focus of Sun Biomedical is on the commercialization of drugs of abuse testing devices with a particular emphasis on saliva devices. The company also possesses a portfolio of research into the use of saliva as a diagnostic medium for other disease states that provide the foundation for continued research and development and a broader portfolio of point of care testing devices.

604 VPR Centre
1001 Lower Landing Road Blackwood, NJ 08012
US ph:18884408388 fax:18564011080

Thu, 17 Apr 2014 12:54:52 GMT
Making a case for space
Jerusalem Post - Apr 17, 2014
We might need to protect earth from an existential threat such as an inbound asteroid or sun flare. Maybe we will dispose of ... Data accumulated by scientists from the biomedical aspects of extended human presence in microgravity at the International ...

Tue, 15 Apr 2014 17:15:28 GMT
Intersex dating: Finding love across the intersection
CNN - Apr 15, 2014
It's not limited to the bedroom," says Ambrose, a writer and the co-founder of The Interface Project, a site that collects and shares personal stories of people living with an intersex condition or DSD.

Fri, 18 Apr 2014 07:05:45 GMT
ARC Plastic Surgery Announces 2104 Spring Promotion - Let My Wrinkles Go
PR Web (press release) - Apr 18, 2014
This cosmetic injection can help reverse the notorious signs of aging such as wrinkles formed between the eyebrows, on the forehead, around the eyes and mouth as a result of frowning, scowling, squinting from the sun, or merely concentrating on a task ...

Michael Cintolo
Investments for Cabot Heritage Corp.
Vice President
Read commentary/listen to interview  

John Dessauer
John Dessauer's Investor's World
Editor of the Finacial Newsletter
Read commentary/listen to interview  

Peter Schiff
Euro Pacific Capital, Inc.
President & Chief Global Strategist
Read commentary/listen to interview  


Sun, 20 Apr 2014 21:20:22 GMT
DealBook: Italian Bank Increases Planned Share Sale to $6.9 Billion

Sun, 20 Apr 2014 01:05:23 GMT
Sending Alerts Instead, G.M. Delayed Car Recalls

Sat, 19 Apr 2014 22:19:42 GMT
Investigating Family’s Wealth, China’s Leader Signals a Change